This holiday season, we want to thank our amazing community of research participants with a special Holiday Referral Giveaway! For every friend you refer to any KGK Science study — or to join our research participant database — you and your friend will each be entered for a chance to...
Clinical research for nutraceuticals has evolved rapidly in recent years, especially with the rise of virtual clinical trials. These decentralized models bring clear advantages such as faster recruitment, larger sample sizes, and lower costs, but also new challenges, including limits on objective data collection and increased participant dropout risk. At...
London, Ontario, Canada, 23 October, 2025 – Cata-Kor, a U.S.-based nutraceutical company, today announced that it has entered into a research services agreement with KGK Science Inc., a leading North American contract research organization (CRO). Under this agreement, KGK will conduct a human clinical trial evaluating NAD+ Advanced, Cata-Kor’s high-dose NAD+...
London, Ontario, Canada, 03 October, 2025 – KGK Science Inc., a leading North American contract research organization and regulatory consulting firm, is proud to announce the successful approval of a Class III Product License Application (PLA) for Qlarity™, a unique product developed by Lucid Psycheceuticals. This approval grants Qlarity™ its...
Hybrid clinical trials are transforming nutraceutical and supplement research by combining virtual and on-site methods. This white paper explores why fully virtual clinical trials often fall short and how a customized hybrid clinical trial model reduces attrition, improves participant engagement, and ensures stronger, more reliable data. Learn how hybrid clinical...
The world of functional foods is evolving rapidly, driven by innovations that promise to deliver real health benefits. Among the most talked-about developments is the potential use of GLP-1 agonists as functional food ingredients. Traditionally prescribed for type 2 diabetes and obesity, GLP-1 agonists mimic the natural glucagon-like peptide 1...
sign up now to be added to our waiting list.
KGK Science has been delivering top-notch clinical research trials and expert regulatory support for the nutraceutical, cannabis, hemp, and psychedelic industries for over 27 years, aiding companies in bringing their products to global markets with custom trials and claim substantiation strategies.
Monday - Saturday 7:00 AM - 3:00 PM
